News & Media

NETA Announces Security Equipment Grant Program to Reduce Financial Barriers for Economic Empowerment and Social Equity Cannabis Businesses
Leading Massachusetts cannabis company to donate $25,000 to two qualifying applicants
Parallel and Cannaclusive Announce Nationwide Partnership to Drive Social Equity Initiatives in the Cannabis Industry
Parallel, one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced its national partnership with Cannaclusive, the leading organization created to facilitate inclusion for both business owners and consumers in the cannabis industry.
Surterra Texas™ Launches First Medical Cannabis Lotions for the Texas Compassionate Use Program
New cannabis-infused lotions provide Texas patients with convenient topical doses of THC and CBD for conditions such as spasticity, multiple sclerosis, terminal cancer, and ALS
Surterra Texas™ Launches First Medical Cannabis Lozenges for the Texas Compassionate Use Program
New cannabis-infused lozenges provide Texas patients with convenient sublingual doses of THC and CBD for conditions such as terminal cancer, spasticity, autism, epilepsy, and incurable neurological diseases.
Surterra Texas™ Launches Medical Cannabis Telehealth Service for the Texas Compassionate Use Program
Telehealth service provided by Heally™ will expand patient access for medical cannabis in Texas
Parallel's Surterra Wellness Stores to Introduce New Products Including Edibles in Florida
A leading Florida cannabis company expands its product offerings for customers
Parallel's Surterra Wellness Brand Announces Corporate Partnership with Cannabis LAB
The collaboration between a leading cannabis company and a reputable organization focused on education for business leaders in the cannabis industry will develop educational programming in addition to communication and media opportunities for industry professionals and the wider Florida medical community.
University of Pittsburgh and Parallel, a Leading Cannabis Company, Join Forces in Pennsylvania Medical Marijuana Research Program
Parallel will provide $3 million in grant funding for clinical studies on sickle cell disease, anxiety and other chronic illnesses; obtains license to operate in Pennsylvania